FLARETX Trademark Information

Trademark by Velox Therapeutics, Inc.

Chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; pharmaceutical preparations for targeting transcription factors; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, and ...

Custom manufacture of biochemical systems, namely, custom manufacture of systems for targeting transcription factors; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders

Bio-technology and scientific services, namely, research, and production and development services relating to bio-technology and science, namely, transcription factors; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, namely, treating therapeutic targets through biochemical preparations; providing a website featuring information...

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (040)
Treatment of materials.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: FLARETX
Status/Status Date:
NEW APPLICATION FILED
5/19/2021
Serial Number: 90533794
Filing Date: 2/18/2021
Foreign Filing Deadline: Wednesday, August 18, 2021
 
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; pharmaceutical preparations for targeting transcription factors; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, and immunological disorders
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner:
Velox Therapeutics, Inc.
Boston, MA 02116
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
COOLEY LLP
1299 PENNSYLVANIA AVENUE NW, SUITE 700
WASHINGTON DC 20004-2400
Current Status:
NEW APPLICATION FILED
5/19/2021
Correspondent Search:
BRENDAN J. HUGHES is a correspondent of FLARETX trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on